Status:
UNKNOWN
The Effects of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Surgical Patients
Lead Sponsor:
University of Zurich
Conditions:
Lower Gastrointestinal Neoplasms Benign
Pancreas Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators want to study whether the use of painting art therapy has an influence on the quality of life, the complication rate and the general outcome of major abdominal surgery. The painting ...
Detailed Description
The interest in alternative and complementary medical treatments has increased significantly in recent years and several studies showed a positive effect on the healing process of patients undergoing ...
Eligibility Criteria
Inclusion
- Consecutive adult patients of both genders ≥ 18 years subjected to major (oncological) surgery due to pathologies of the pancreatic and lower gastrointestinal tract at our department.
- The initial diagnosis does not date back longer than 6 months prior the planned surgery. Neoadjuvant radio-/chemotherapy is not an exclusion criteria.
- Able to speak and understand German or English
- Signed written informed consent by the participant after extensive oral and written information about the research project and its aims.
- Thresholds of primary outcome: anxiety levels measured with STAI-form Y-1 (state) and Y-2 (trait). Thresholds: scores between 20 (minimum) and 80 (maximum) in each subscore.
Exclusion
- Woman who are pregnant or breast feeding.
- Known or suspected non-compliance regarding the execution of painting art therapy and/or the proper completion of the needed forms.
- Drug or alcohol abuse.
- Regular intake of antidepressant medication with the exception of medication prescribed for chronic insomnia.
- Acute suicidality.
- Life expectancy less than 9 months after planned surgery.
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, ect. of the participant
- Participation in another study during the present study and within 6 weeks following the surgery.
- Previous enrollment into the current study.
- Enrollment of the investigator, his/her family members, employees and other dependent persons.
Key Trial Info
Start Date :
August 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04524260
Start Date
August 31 2020
End Date
February 28 2023
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Visceral- and Transplantation Surgery, University Hospital Zurich
Zurich, Canton of Zurich, Switzerland, 8091